These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3440257)

  • 1. Radiochemotherapy with 125I-5-iodo-2-deoxyuridine.
    Bagshawe KD
    Cancer Treat Rev; 1987 Dec; 14(3-4):397-9. PubMed ID: 3440257
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-123I/125I-iodo-2'-deoxyuridine for cancer diagnosis and therapy.
    Kassis AI
    J Nucl Med Allied Sci; 1990; 34(4):299-303. PubMed ID: 2090794
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Kassis AI; Adelstein SJ
    Acta Oncol; 1996; 35(7):935-9. PubMed ID: 9004774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
    Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
    J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases.
    Sgouros G; O'Donoghue JA; Larson SM; Macapinlac H; Larson JJ; Kemeny N
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1177-83. PubMed ID: 9719130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.
    Riches AC; Gore D; Docherty J; Littlewood V
    J Anat; 1976 Apr; 121(Pt 2):323-9. PubMed ID: 58855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
    Sahu SK; Wen PY; Foulon CF; Nagel JS; Black PM; Adelstein SJ; Kassis AI
    J Nucl Med; 1997 Mar; 38(3):386-90. PubMed ID: 9074525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD; Adelstein SJ
    Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.